Clinical Trial Results: Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results for SP-103 in adults with moderate to severe acute lower back pain have been completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Back Pain

Drugs mentioned

• SP-103

Snippet

Sponsor: Scilex Pharmaceuticals, Inc. | Conditions: Moderate to Severe Acute Lower Back Pain | Phase 2 | Status: COMPLETED | Results posted: 2026-07-06